ATP-Bio evaluates its preservation technologies across three classes of biological systems, increasing in complexity, which serve as platforms for both discovery and translation.

Cells and Organoids – Including rapidly advancing regenerative medicine and cell therapy systems such as CAR-T cells, which currently lack reliable cryopreservation methods.

Organs – From zebrafish to pigs, including gene-edited organs for xenotransplantation.

Organisms – Extending to model systems for healthcare, aquaculture, agricultural products, synthetic foods, and the preservation of genetic material from endangered species.

These testbeds provide real-world platforms to validate advances from all three Integrated Thrust Areas, ensuring that innovations are robust, scalable, and applicable across biological scales.